scPharmaceuticals Inc.

NASDAQ:SCPH

5.43 (USD) • At close September 18, 2024
Bedrijfsnaam scPharmaceuticals Inc.
Symbool SCPH
Munteenheid USD
Prijs 5.43
Beurswaarde 271,656,384
Dividendpercentage 0%
52-weken bereik 3.24 - 7.55
Industrie Biotechnology
Sector Healthcare
CEO Mr. John H. Tucker
Website https://www.scpharmaceuticals.com

An error occurred while fetching data.

Over scPharmaceuticals Inc.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone,

Vergelijkbare Aandelen

Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc.

ABOS

2.44 USD

Spok Holdings, Inc. logo

Spok Holdings, Inc.

SPOK

15.27 USD

PDS Biotechnology Corporation logo

PDS Biotechnology Corporation

PDSB

3.07 USD

TFF Pharmaceuticals, Inc. logo

TFF Pharmaceuticals, Inc.

TFFP

2.28 USD

Sensus Healthcare, Inc. logo

Sensus Healthcare, Inc.

SRTS

6.07 USD

ProPhase Labs, Inc. logo

ProPhase Labs, Inc.

PRPH

2.45 USD

Allakos Inc. logo

Allakos Inc.

ALLK

0.54 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)